{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:20:16Z","timestamp":1772428816374,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GPO-A-00-04-00019-00"],"award-info":[{"award-number":["GPO-A-00-04-00019-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13346-017-0421-4","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T13:25:10Z","timestamp":1502803510000},"page":"859-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1"],"prefix":"10.1007","volume":"7","author":[{"given":"Olga","family":"Mizenina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayla","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninochka","family":"Jean-Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meropi","family":"Aravantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Levendosky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Paglini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Zydowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Robbiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-0482","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Fern\u00e1ndez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"issue":"1","key":"421_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1128\/AAC.05461-11","volume":"56","author":"JA Fernandez-Romero","year":"2012","unstructured":"Fernandez-Romero JA, Abraham CJ, Rodriguez A, Kizima L, Jean-Pierre N, Menon R, et al. Zinc acetate\/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob Agents Chemother. 2012;56(1):358\u201368.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"421_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.olq.0000223287.46097.4b","volume":"34","author":"JA Fernandez-Romero","year":"2007","unstructured":"Fernandez-Romero JA, Thorn M, Turville SG, Titchen K, Sudol K, Li J, et al. Carrageenan\/MIV-150 (PC-815), a combination microbicide. Sex Transm Dis. 2007;34(1):9\u201314.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"421_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/aid.2013.0165","volume":"30","author":"M Hsu","year":"2014","unstructured":"Hsu M, Aravantinou M, Menon R, Seidor S, Goldman D, Kenney J, et al. A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge. AIDS Res Hum Retrovir. 2014;30(2):174\u201383.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"421_CR4","doi-asserted-by":"publisher","first-page":"e15835","DOI":"10.1371\/journal.pone.0015835","volume":"6","author":"J Kenney","year":"2011","unstructured":"Kenney J, Aravantinou M, Singer R, Hsu M, Rodriguez A, Kizima L, et al. An antiretroviral\/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. PLoS One. 2011;6(1):e15835.","journal-title":"PLoS One"},{"issue":"8","key":"421_CR5","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1128\/AAC.00796-13","volume":"57","author":"J Kenney","year":"2013","unstructured":"Kenney J, Rodriguez A, Kizima L, Seidor S, Menon R, Jean-Pierre N, et al. A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo. Antimicrob Agents Chemother. 2013;57(8):4001\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"421_CR6","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1089\/aid.2012.0087","volume":"28","author":"J Kenney","year":"2012","unstructured":"Kenney J, Singer R, Derby N, Aravantinou M, Abraham CJ, Menon R, et al. A single dose of a MIV-150\/zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use. AIDS Res Hum Retrovir. 2012;28(11):1476\u201384.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"421_CR7","doi-asserted-by":"publisher","first-page":"e94547","DOI":"10.1371\/journal.pone.0094547","volume":"9","author":"L Kizima","year":"2014","unstructured":"Kizima L, Rodriguez A, Kenney J, Derby N, Mizenina O, Menon R, et al. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS One. 2014;9(4):e94547.","journal-title":"PLoS One"},{"issue":"5","key":"421_CR8","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1128\/AAC.01529-13","volume":"58","author":"LA Ouattara","year":"2014","unstructured":"Ouattara LA, Barnable P, Mawson P, Seidor S, Zydowsky TM, Kizima L, et al. MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection. Antimicrob Agents Chemother. 2014;58(5):2841\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"421_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.antiviral.2014.05.018","volume":"108","author":"A Rodriguez","year":"2014","unstructured":"Rodriguez A, Kleinbeck K, Mizenina O, Kizima L, Levendosky K, Jean-Pierre N, et al. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antivir Res. 2014;108:88\u201393.","journal-title":"Antivir Res"},{"issue":"11","key":"421_CR10","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1128\/JVI.02422-10","volume":"85","author":"R Singer","year":"2011","unstructured":"Singer R, Derby N, Rodriguez A, Kizima L, Kenney J, Aravantinou M, et al. The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian\/human immunodeficiency virus infection in macaques. J Virol. 2011;85(11):5504\u201312.","journal-title":"J Virol"},{"issue":"150","key":"421_CR11","doi-asserted-by":"publisher","first-page":"150ra23","DOI":"10.1126\/scitranslmed.3003936","volume":"4","author":"R Singer","year":"2012","unstructured":"Singer R, Mawson P, Derby N, Rodriguez A, Kizima L, Menon R, et al. An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci Transl Med. 2012;4(150):150ra23.","journal-title":"Sci Transl Med"},{"issue":"3","key":"421_CR12","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1097\/QAI.0000000000001167","volume":"74","author":"G Calenda","year":"2017","unstructured":"Calenda G, Villegas G, Barnable P, Litterst C, Levendosky K, Gettie A, et al. MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa. J Acquir Immune Defic Syndr. 2017;74(3):e67\u201374.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"421_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/QAI.0000000000001136","volume":"73","author":"BA Friedland","year":"2016","unstructured":"Friedland BA, Hoesley CJ, Plagianos M, Hoskin E, Zhang S, Teleshova N, et al. First-in-human trial of MIV-150 and zinc acetate coformulated in a carrageenan gel: safety, pharmacokinetics, acceptability, adherence, and pharmacodynamics. J Acquir Immune Defic Syndr. 2016;73(5):489\u201396.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"421_CR14","doi-asserted-by":"publisher","unstructured":"Derby N, Aravantinou M, Kenney J, Ugaonkar SR, Wesenberg A, Wilk J, et al. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques. Drug Deliv Transl Res. 2017. doi:10.1007\/s13346-017-0389-0.","DOI":"10.1007\/s13346-017-0389-0"},{"key":"421_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2015.06.018","volume":"213","author":"SR Ugaonkar","year":"2015","unstructured":"Ugaonkar SR, Wesenberg A, Wilk J, Seidor S, Mizenina O, Kizima L, et al. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. J Control Release. 2015;213:57\u201368.","journal-title":"J Control Release"},{"issue":"3","key":"421_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jac\/dki464","volume":"57","author":"OJ D'Cruz","year":"2006","unstructured":"D'Cruz OJ, Uckun FM. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J Antimicrob Chemother. 2006;57(3):411\u201323.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"421_CR17","doi-asserted-by":"publisher","first-page":"e89300","DOI":"10.1371\/journal.pone.0089300","volume":"9","author":"M Hsu","year":"2014","unstructured":"Hsu M, Keele BF, Aravantinou M, Krawczyk N, Seidor S, Abraham CJ, et al. Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques. PLoS One. 2014;9(2):e89300.","journal-title":"PLoS One"},{"issue":"7","key":"421_CR18","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1128\/AAC.00073-15","volume":"59","author":"P Barnable","year":"2015","unstructured":"Barnable P, Calenda G, Bonnaire T, Menon R, Levendosky K, Gettie A, et al. MIV-150\/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model. Antimicrob Agents Chemother. 2015;59(7):3829\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"421_CR19","doi-asserted-by":"publisher","first-page":"e108109","DOI":"10.1371\/journal.pone.0108109","volume":"9","author":"P Barnable","year":"2014","unstructured":"Barnable P, Calenda G, Ouattara L, Gettie A, Blanchard J, Jean-Pierre N, et al. A MIV-150\/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants. PLoS One. 2014;9(9):e108109.","journal-title":"PLoS One"},{"issue":"17","key":"421_CR20","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1128\/JVI.79.17.11179-11186.2005","volume":"79","author":"P Fletcher","year":"2005","unstructured":"Fletcher P, Kiselyeva Y, Wallace G, Romano J, Griffin G, Margolis L, et al. The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells. J Virol. 2005;79(17):11179\u201386.","journal-title":"J Virol"},{"issue":"2","key":"421_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/AAC.01156-08","volume":"53","author":"P Fletcher","year":"2009","unstructured":"Fletcher P, Harman S, Azijn H, Armanasco N, Manlow P, Perumal D, et al. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2009;53(2):487\u201395.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"421_CR22","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/JCM.38.5.1758-1762.2000","volume":"38","author":"M Arens","year":"2000","unstructured":"Arens M, Travis S. Zinc salts inactivate clinical isolates of herpes simplex virus in vitro. J Clin Microbiol. 2000;38(5):1758\u201362.","journal-title":"J Clin Microbiol"},{"issue":"Pt 12","key":"421_CR23","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1099\/0022-1317-71-12-2989","volume":"71","author":"G Kumel","year":"1990","unstructured":"Kumel G, Schrader S, Zentgraf H, Daus H, Brendel M. The mechanism of the antiherpetic activity of zinc sulphate. J Gen Virol. 1990;71(Pt 12):2989\u201397.","journal-title":"J Gen Virol"},{"issue":"1","key":"421_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1073\/pnas.70.1.164","volume":"70","author":"W Levinson","year":"1973","unstructured":"Levinson W, Faras A, Woodson B, Jackson J, Bishop JM. Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations. Proc Natl Acad Sci U S A. 1973;70(1):164\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"421_CR25","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1128\/JVI.07115-11","volume":"86","author":"CY Liu","year":"2012","unstructured":"Liu CY, Kielian M. Identification of a specific region in the e1 fusion protein involved in zinc inhibition of semliki forest virus fusion. J Virol. 2012;86(7):3588\u201394.","journal-title":"J Virol"},{"issue":"3","key":"421_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.antiviral.2012.09.020","volume":"96","author":"TE Antoine","year":"2012","unstructured":"Antoine TE, Mishra YK, Trigilio J, Tiwari V, Adelung R, Shukla D. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection. Antivir Res. 2012;96(3):363\u201375.","journal-title":"Antivir Res"},{"issue":"1","key":"421_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1128\/JVI.01543-08","volume":"83","author":"BM Krenn","year":"2009","unstructured":"Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJ, Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol. 2009;83(1):58\u201364.","journal-title":"J Virol"},{"issue":"11","key":"421_CR28","doi-asserted-by":"publisher","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","volume":"6","author":"AJ te Velthuis","year":"2010","unstructured":"te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176.","journal-title":"PLoS Pathog"},{"issue":"5","key":"421_CR29","doi-asserted-by":"publisher","first-page":"e37398","DOI":"10.1371\/journal.pone.0037398","volume":"7","author":"S Karki","year":"2012","unstructured":"Karki S, Li MM, Schoggins JW, Tian S, Rice CM, MacDonald MR. Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS One. 2012;7(5):e37398.","journal-title":"PLoS One"},{"issue":"6","key":"421_CR30","doi-asserted-by":"publisher","first-page":"e39159","DOI":"10.1371\/journal.pone.0039159","volume":"7","author":"X Wang","year":"2012","unstructured":"Wang X, Tu F, Zhu Y, Gao G. Zinc-finger antiviral protein inhibits XMRV infection. PLoS One. 2012;7(6):e39159.","journal-title":"PLoS One"},{"key":"421_CR31","unstructured":"Kelly P, InventorGenital lubricants containing zinc salts to reduce risk of HIV infection, U. Patent, Editor. USA 1997."},{"issue":"47","key":"421_CR32","doi-asserted-by":"publisher","first-page":"40433","DOI":"10.1074\/jbc.M111.289850","volume":"286","author":"KJ Fenstermacher","year":"2011","unstructured":"Fenstermacher KJ, DeStefano JJ. Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity. J Biol Chem. 2011;286(47):40433\u201342.","journal-title":"J Biol Chem"},{"issue":"11","key":"421_CR33","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.73.11.8966-8974.1999","volume":"73","author":"A Trkola","year":"1999","unstructured":"Trkola A, Matthews J, Gordon C, Ketas T, Moore JP. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol. 1999;73(11):8966\u201374.","journal-title":"J Virol"},{"issue":"9","key":"421_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/aid.2010.0252","volume":"27","author":"O Begay","year":"2011","unstructured":"Begay O, Jean-Pierre N, Abraham CJ, Chudolij A, Seidor S, Rodriguez A, et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retrovir. 2011;27(9):1019\u201324.","journal-title":"AIDS Res Hum Retrovir"},{"key":"421_CR35","unstructured":"Thermo Fisher Scientific. CyQuant Direct Cell Proliferation Assay Kit. https:\/\/www.thermofisher.com\/order\/catalog\/product\/C35011."},{"issue":"3","key":"421_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58(3):621\u201381.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"421_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","volume":"85","author":"MP de Bethune","year":"2010","unstructured":"de Bethune MP. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009). Antivir Res. 2010;85(1):75\u201390.","journal-title":"Antivir Res"},{"issue":"11","key":"421_CR38","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/503914","volume":"42","author":"TF Liu","year":"2006","unstructured":"Liu TF, Shafer RW. Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis. 2006;42(11):1608\u201318.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"421_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/eri.12.155","volume":"11","author":"N Derby","year":"2013","unstructured":"Derby N, Zydowsky T, Robbiani M. In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward? Expert Rev Anti-Infect Ther. 2013;11(1):5\u20138.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"7","key":"421_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","volume":"23","author":"JA Fernandez-Romero","year":"2015","unstructured":"Fernandez-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, et al. Multipurpose prevention technologies: the future of HIV and STI protection. Trends Microbiol. 2015;23(7):429\u201336.","journal-title":"Trends Microbiol"},{"issue":"3","key":"421_CR41","first-page":"256","volume":"46","author":"JA Fern\u00e1ndez-Romero","year":"2014","unstructured":"Fern\u00e1ndez-Romero JA, Gil PI, R\u00e9 V, Robbiani M, Paglini G. Current status of microbicides for prevention of sexually transmitted infections and strategies for preclinical evaluation of new candidates. Rev Argent Microbiol. 2014;46(3):256\u201368.","journal-title":"Rev Argent Microbiol"},{"key":"421_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2014.12.005","volume":"92","author":"JA Fernandez-Romero","year":"2015","unstructured":"Fernandez-Romero JA, Teleshova N, Zydowsky TM, Robbiani M. Preclinical assessments of vaginal microbicide candidate safety and efficacy. Adv Drug Deliv Rev. 2015;92:27\u201338.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-017-0421-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0421-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0421-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:42:07Z","timestamp":1659098527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-017-0421-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0421-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]},"assertion":[{"value":"15 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the experiments published in this manuscript comply with the current laws of the country in which they were performed. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"O. Mizenina, M. Hsu, N. Jean-Pierre, M. Aravantinou, K. Levendosky, G. Paglini, T.M. Zydowsky, M. Robbiani, and J. A. Fern\u00e1ndez-Romero declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}